BP
SBRA icon

Ballentine Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Ballentine Partners’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,277
Closed -$270K – 1080
2025
Q4 		$270K Sell
14,277
-161
-1% -$2.98K ﹤0.01% 760
2025
Q3 		$269K Buy
14,438
+870
+6% +$16.3K ﹤0.01% 777
2025
Q2 		$250K Buy
13,568
+1,090
+9% +$19.3K ﹤0.01% 775
2025
Q1 		$218K Buy
+12,478
New +$210K ﹤0.01% 762

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ballentine Partners's SBRA Position: Q1 2026 in Review

Ballentine Partners sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 14,277 shares — an estimated $270K sold.

Ballentine Partners first reported a position in SBRA in Q1 2025 and held it in 4 quarters. The position peaked at $270K in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Ballentine Partners reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
  • Ballentine Partners sold 14,277 Sabra Healthcare REIT shares in Q1 2026, an estimated $270K.
  • Ballentine Partners first reported a position in Sabra Healthcare REIT in Q1 2025 and held it in 4 quarters.
  • Ballentine Partners's Sabra Healthcare REIT position peaked at $270K in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Ballentine Partners's 13F filing for Q1 2026, filed 14 May 2026.